To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
119th Congress
HR 1843 boosts transparency in generic drug applications, ensuring clearer info on equivalence for manufacturers, improving access to reliable, affordable medications for consumers.
Introduced in House
Start the Conversation
Be the first to share your thoughts on this petition. Your voice matters!